Correlation Between Viatris and COSCIENS Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viatris and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and COSCIENS Biopharma, you can compare the effects of market volatilities on Viatris and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and COSCIENS Biopharma.

Diversification Opportunities for Viatris and COSCIENS Biopharma

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Viatris and COSCIENS is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Viatris i.e., Viatris and COSCIENS Biopharma go up and down completely randomly.

Pair Corralation between Viatris and COSCIENS Biopharma

Given the investment horizon of 90 days Viatris is expected to generate 0.75 times more return on investment than COSCIENS Biopharma. However, Viatris is 1.33 times less risky than COSCIENS Biopharma. It trades about 0.19 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.12 per unit of risk. If you would invest  1,160  in Viatris on September 1, 2024 and sell it today you would earn a total of  149.00  from holding Viatris or generate 12.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Viatris  vs.  COSCIENS Biopharma

 Performance 
       Timeline  
Viatris 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Viatris may actually be approaching a critical reversion point that can send shares even higher in December 2024.
COSCIENS Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days COSCIENS Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Viatris and COSCIENS Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viatris and COSCIENS Biopharma

The main advantage of trading using opposite Viatris and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.
The idea behind Viatris and COSCIENS Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments